Business & Finance
RaySearch Laboratories' RayStation selected by Emory Proton Therapy Centre in Atlanta
9 July 2018 -

Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Friday that during March 2018, its RayStation was selected as treatment planning system for Emory Proton Therapy Centre, owned and operated by Provident Resources Group Inc.

This new facility is currently under construction in Atlanta, Georgia, and is scheduled to treat its first patients in late 2018.

According to the company, the comprehensive RayStation installation includes VMAT, pencil beam scanning, multi-criteria optimisation, biological optimisation, fallback planning, deformable registration, dose tracking, adaptive replanning and contouring.

Reportedly, the majority of this order has been delivered and generated revenues in the first quarter of 2018. Financial details of this order were not available.

RayStation integrates all RaySearch's advanced treatment planning solutions into a flexible treatment planning system. It combines features such as multi-criteria optimisation tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch's algorithms for IMRT and VMAT optimisation and highly accurate dose engines for photon, electron, proton and carbon ion therapy.

RaySearch Laboratories develops software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies.

Login
Username:

Password: